Peter Verwaijen
Vendite & Marketing presso EGETIS THERAPEUTICS AB
Posizioni attive di Peter Verwaijen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Vendite & Marketing | 05/05/2022 | - |
Storia della carriera di Peter Verwaijen
Precedenti posizioni note di Peter Verwaijen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Direttore Finanziario/CFO | 17/04/2009 | - |
Glaucus Proteomics BV
 Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Comptroller/Controller/Auditor | - | - |
Statistiche
Distribuzione geografica
| Paesi Bassi | 3 |
| Svezia | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Sales & Marketing | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Aziende private | 2 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Peter Verwaijen
- Esperienza
